Patents Assigned to RONTIS HELLAS S.A.
  • Publication number: 20200254152
    Abstract: The present invention relates to a coating system for medical devices comprising at least one cellulose compound or derivative thereof alone or in combination with other substances. The coating system may further comprise at least one active ingredient intended to treat a disease and the coating has favorable drug eluting properties. The present invention has applications in implantable or non-implantable medical devices such as balloons, stents, grafts, patches and implants of all kinds.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 13, 2020
    Applicant: RONTIS HELLAS S.A.
    Inventor: ANARGYROS MOULAS
  • Publication number: 20170246354
    Abstract: The present invention relates to a drug eluting device for preventing and treating restenosis and neointimal formation after vascular procedures and/or implantation of implants comprising an implantable or non-implantable device, such as stent, balloon or graft containing an effective amount of at least one retinoid receptors ligand as active ingredient and a coating system.
    Type: Application
    Filed: December 2, 2015
    Publication date: August 31, 2017
    Applicant: RONTIS HELLAS S.A.
    Inventor: ANARGYROS MOULAS